Erector Spinae Plane Block in Congenital Heart Disease Patients

Launched by STANFORD UNIVERSITY · Nov 7, 2019

Keywords

ClinConnect Summary

This clinical trial is investigating a new method of pain relief called the erector spinae plane block (ESPB) for children with congenital heart disease who are undergoing surgery. Researchers want to see if this technique can help reduce the amount of anesthesia needed during surgery and improve recovery while lowering the risk of neurological problems, which can be a concern for these young patients. The ESPB is a type of regional anesthesia that is thought to be safer than traditional methods, especially during heart surgeries where certain risks are present.

To be eligible for this trial, children who are admitted for heart surgery at The Lucile Packard Children's Hospital will need to be at least 32 weeks old, either born prematurely or as infants or older children with specific heart conditions. However, babies born before 32 weeks, those with certain brain abnormalities, or those who might need special life support after surgery will not be included. If your child is eligible and participates, they can expect to receive this new type of pain management during their surgery, which might help with their recovery and overall health outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Neonates of at least 32 weeks of gestation, infants and children admitted to The Lucile Packard Children's Hospital for treatment of cyanotic or non-cyanotic heart disease requiring surgical intervention.
• • Admitting diagnosis of cyanotic or non-cyanotic heart disease
• Exclusion Criteria:
• • Neonates less than 32 weeks of gestational age
• • Any documented central nervous system malformations.
• • Any potential subject requiring unexpected postoperative Extracorporeal membrane oxygenation (ECMO) support